Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In



Facing two-year ban, Ulissi has Italy’s support

The Lampre-Merida rider failed an anti-doping test during the Giro d'Italia in May

Heading out the door? Read this article on the new Outside+ app available now on iOS devices for members! Download the app.

MILAN (VN) — Italy’s head coach Davide Cassani spoke in support of Diego Ulissi (Lampre-Merida) after news hit Wednesday that he failed an anti-doping test for asthma drug Salbutamol during the Giro d’Italia.

“I am concerned that people understand one thing, that Salbutamol doesn’t make you go stronger, it’s an accepted product,” Cassani told Italy’s La Gazzetta dello Sport newspaper Thursday.

“Cyclists know that if you take five puffs then you won’t go any faster. You need to understand that this isn’t doping, that it doesn’t better your performance and is not a masking agent.”

Lampre announced its Giro star exceeded the accepted limit of Salbutamol in his urine in an anti-doping control after stage 11 of the three-week race through Italy last month. The 24-year-old from Tuscany had already won two stages, and the next day he placed second in the time trial in Barolo. He abandoned the race after stage 17 while on antibiotics to fight a sore throat and temperature.

Ulissi was using an inhaler with Salbutamol spray for bronchospasm and, according to Lampre, he took two puffs ahead of stage 11. He was also given paracetamol from the race doctor after a mid-stage crash. The team reported that his urine showed 1900 nanograms per milliliter of Salbutamol, nearly double the limit of 1000ng/ml.

The UCI and World Anti-Doping Agency (WADA) only require a Therapeutic Use Exemption (TUE) for the asthma drug if more than 1600mg is used per day, or around 14 to 17 puffs. The drug was recently in the news during the Critérium du Dauphiné two weeks ago when television cameras showed reigning Tour de France champion Chris Froome (Sky) using an inhaler in the final kilometers of a mountain stage.

“It’s quite common for endurance athletes to have exercise-induced problems,” Froome said, “so I’m not alone in that problem.”

Assuming the test results are correct, however, Ulissi would have over-used the drug and broken anti-doping rules. He will face Swiss Cycling’s anti-doping committee — he lives near Lugano — and a possible two-year ban. Lampre said yesterday that Ulissi will try to show why the levels could have been so high.

“He called me,” said Cassani. “He said, ‘I took those puffs in front of the doctor. One, two or three days before, I didn’t take it, only those two puffs.’ I believe he was telling me the truth, besides we are talking about Salbutamol and not EPO.”

Some cyclists like Leonardo Piepoli have been pardoned in the past but others like Alessandro Petacchi served bans for over-use. Petacchi, who said he accidentally took too many sprays at the 2007 Giro, served a nine-month ban.

Salbutamol could help more than the airways. Studies in the last decade have shown that like Clenbuterol, the drug that came to light when Alberto Contador tested positive at the 2010 Tour de France, Salbutamol helps burn fat and tone muscle.

Ulissi will have to explain himself in Switzerland and if sentenced, will have the right to appeal the case to the Court of Arbitration for Sport.

An American in France

What’s it like to be an American cyclist living in France? Watch to get professional road cyclist Joe Dombrowski’s view.